Q Therapeutics’ Collaborators at Johns Hopkins Receive $1 Million to Study Glial Cells for Neurodegerative Conditions

Dr. Piotr Walczak, M.D., of Johns Hopkins University, will be awarded a $1 million grant by the Maryland Stem Cell Research Fund to enable further study of Q Therapeutic’s glial cell-based therapeutic (“Q-Cells”) for the treatment of neurodengenerative disease.

Click here to read more.

Share this: